Posted inCardiagtech

Differential Diagnosis of Tachycardia: A Comprehensive Guide for Clinicians

No Comments

Sinus tachycardia, characterized by a heart rate exceeding the normal range, is a common clinical finding. While often a physiological response to exertion or stress, tachycardia at rest can signal underlying pathology. Accurate diagnosis is paramount to determine the etiology and guide appropriate management. This article provides a detailed overview of the Differential Diagnosis Of Tachycardia, crucial for healthcare professionals in evaluating and treating patients effectively.

Understanding Tachycardia: Etiology and Initial Assessment

Tachycardia, by definition, is a heart rate above the normal resting range. For adults, this typically means a heart rate greater than 100 beats per minute. It’s essential to first differentiate between physiological and pathological causes. Physiological tachycardia is often triggered by catecholamines released during exercise, emotional stress, pain, or anxiety. However, when tachycardia occurs at rest, a more thorough investigation is warranted to rule out pathological etiologies, which can be broadly categorized into cardiac and non-cardiac causes.

Cardiac Etiologies of Tachycardia

Cardiac causes of tachycardia involve conditions directly affecting the heart’s electrical conduction system or myocardial function. These include:

  • Supraventricular Tachycardias (SVTs): Originating above the ventricles, SVTs are characterized by a narrow QRS complex on an electrocardiogram (ECG). Subtypes include:

    • Atrial Fibrillation: An irregular rhythm with absent P waves, potentially leading to rapid ventricular rates.
    • Atrial Flutter: Typically presents with a regular rhythm and a characteristic “sawtooth” pattern on ECG.
    • Atrioventricular Nodal Reentrant Tachycardia (AVNRT): A paroxysmal SVT with abrupt onset and termination, often with a rapid, regular rhythm.
    • Atrioventricular Reentrant Tachycardia (AVRT): Involves an accessory pathway, potentially leading to a regular, rapid rhythm.
    • Atrial Tachycardia: A regular rhythm originating from an ectopic focus in the atria.

  • Ventricular Tachycardia (VT): Originating in the ventricles, VT is defined by a wide QRS complex on ECG. It can be life-threatening, especially if sustained or polymorphic.

    • Monomorphic VT: Consistent QRS morphology, often associated with structural heart disease.
    • Polymorphic VT: Variable QRS morphology, including Torsades de Pointes, often linked to QT interval prolongation.

  • Torsades de Pointes: A specific type of polymorphic VT associated with prolonged QT interval, increasing the risk of sudden cardiac death. Factors like medications, electrolyte imbalances, and congenital long QT syndrome predispose to this arrhythmia.

  • Myocarditis: Inflammation of the heart muscle, frequently caused by viral infections, but also bacterial, parasitic, autoimmune, or toxic insults. Myocarditis can disrupt normal electrical activity and lead to tachycardia.

  • Cardiac Tamponade: Pressure on the heart due to fluid accumulation in the pericardial sac. This impairs ventricular filling and reduces cardiac output, triggering compensatory tachycardia. Classic signs include hypotension, jugular venous distention, and muffled heart sounds.

  • Acute Coronary Syndrome (ACS): Ischemia from reduced blood flow to the heart muscle, encompassing unstable angina, NSTEMI, and STEMI. Pain and stress associated with ACS can induce tachycardia.

Non-Cardiac Pathological Etiologies of Tachycardia

Beyond cardiac conditions, numerous non-cardiac factors can precipitate tachycardia. These include:

Respiratory Conditions:

  • Pulmonary Embolism (PE): Blockage of pulmonary arteries, often by blood clots, impairs oxygenation and increases cardiac workload, leading to tachycardia.

  • Hypoxia: Insufficient oxygen supply to tissues due to various respiratory or circulatory issues. The body compensates with tachycardia to improve oxygen delivery.

Gastrointestinal, Renal, and Electrolyte Imbalances:

  • Hypoglycemia: Low blood glucose levels trigger catecholamine release, resulting in tachycardia.

  • Dehydration: Reduced intravascular volume decreases preload, and tachycardia is a compensatory mechanism to maintain cardiac output.

  • Electrolyte Imbalances:

    • Hyperkalemia: Elevated potassium levels, though more commonly associated with bradycardia, can paradoxically cause tachycardia in certain contexts.
    • Hypomagnesemia: Low magnesium levels can increase cardiac excitability and contribute to arrhythmias, including tachycardia.
    • Hypocalcemia: Low calcium levels affect cardiac contractility and electrical stability, potentially leading to tachycardia.

Infectious Diseases:

  • Sepsis: Systemic inflammatory response to infection, causing vasodilation and reduced systemic vascular resistance. Tachycardia is an early compensatory response to maintain blood pressure and tissue perfusion.

Vascular Issues:

  • Shock: A state of inadequate tissue perfusion and oxygenation, classified into distributive, hypovolemic, cardiogenic, and obstructive types. Tachycardia is a hallmark of most forms of shock as the body attempts to compensate for reduced circulatory function.

Hematologic Conditions:

  • Hemorrhage: Blood loss reduces intravascular volume, triggering compensatory tachycardia. The severity of tachycardia correlates with the volume of blood lost.

  • Anemia: Reduced hemoglobin or red blood cell count decreases oxygen-carrying capacity. Tachycardia is a compensatory response to enhance oxygen delivery to tissues.

Toxicological Causes:

  • Medications: Numerous drugs can induce tachycardia as a side effect, including bronchodilators (albuterol), stimulants (amphetamines, caffeine, cocaine), anticholinergics, antihistamines, thyroid hormone (levothyroxine), and tricyclic antidepressants.

  • Substance Withdrawal: Withdrawal from alcohol, benzodiazepines, beta-blockers, and opioids can lead to a hyperadrenergic state characterized by tachycardia.

Endocrinological Factors:

  • Pregnancy: Physiological changes in pregnancy, including increased blood volume and cardiac output, naturally elevate heart rate.

  • Hyperthyroidism: Excess thyroid hormone increases metabolic rate and sympathetic activity, commonly causing tachycardia, palpitations, and atrial fibrillation.

  • Pheochromocytoma and Paraganglioma: These neuroendocrine tumors secrete catecholamines, leading to episodic or sustained hypertension and tachycardia, along with diaphoresis, anxiety, and headaches.

Life-threatening etiologies are denoted with an asterisk ().*

Epidemiology of Sinus Tachycardia

Sinus tachycardia itself is a frequent and often transient rhythm. Inappropriate sinus tachycardia (IST), a diagnosis of exclusion, refers to unexplained sinus tachycardia not attributable to identifiable physiological or pathological causes. IST is considered rare and more prevalent in young women and healthcare professionals. Postural orthostatic tachycardia syndrome (POTS) is another condition seen predominantly in young women, characterized by excessive tachycardia upon standing, often following stress events like infections or surgery.

History, Physical Examination, and Initial Evaluation

A comprehensive history and physical examination are crucial in the differential diagnosis of tachycardia. Key historical points include:

  • Symptom Onset and Duration: Sudden onset suggests paroxysmal SVTs, while gradual onset may indicate sinus tachycardia related to underlying conditions.
  • Precipitating Factors: Exercise, stress, medications, substance use, recent illness, or surgeries.
  • Associated Symptoms: Palpitations, chest pain, dyspnea, lightheadedness, dizziness, syncope, or pre-syncope.
  • Past Medical History: Known heart disease, thyroid disorders, anemia, or other relevant conditions.
  • Medication and Substance Use: Prescription drugs, over-the-counter medications, caffeine, alcohol, and illicit drug use.
  • Family History: History of arrhythmias, sudden cardiac death, or inherited cardiac conditions.

Physical examination should focus on:

  • Hemodynamic Status: Assess blood pressure, heart rate, respiratory rate, and oxygen saturation to identify signs of shock or instability.
  • Cardiovascular Examination: Auscultate heart sounds for murmurs, gallops, or muffled sounds. Evaluate for jugular venous distention and pulsus paradoxus, which may suggest cardiac tamponade.
  • General Examination: Look for signs of underlying conditions like hyperthyroidism (tremor, goiter, eye signs), anemia (pallor), or infection (fever).

Initial evaluation typically includes:

  • 12-lead ECG: Essential to confirm tachycardia, identify the rhythm (sinus tachycardia vs. other tachyarrhythmias), and look for signs of ischemia, QT prolongation, or other abnormalities.

Figure: ECG showing sinus tachycardia at 150 bpm and right bundle branch block in a patient with pulmonary embolism. Illustrates the electrocardiographic findings in tachycardia associated with a respiratory condition.

Diagnostic Tests for Differential Diagnosis

Further investigations are guided by the clinical presentation and suspected etiologies. Common diagnostic tests include:

  • Continuous ECG Monitoring (Holter or Event Monitor): Useful for capturing intermittent tachycardia and evaluating for inappropriate sinus tachycardia.
  • Pulse Oximetry: To assess for hypoxia.
  • Echocardiogram: Evaluates cardiac structure and function, ruling out structural heart disease, cardiomyopathy, or pericardial effusion.
  • Arterial Blood Gas (ABG): Assesses oxygenation, ventilation, and acid-base status, particularly in patients with respiratory symptoms or suspected hypoxia.
  • Lactate Level: Elevated lactate suggests tissue hypoperfusion, indicative of shock or sepsis.
  • Chest X-ray: Detects pneumonia, pneumothorax, pulmonary edema, or cardiomegaly.
  • D-dimer and CT Pulmonary Angiography (CTPA) or V/Q Scan: To rule out pulmonary embolism in patients with respiratory symptoms or risk factors.
  • Cardiac Enzymes (Troponin): Elevated levels suggest myocardial injury, as in acute coronary syndrome or myocarditis.
  • Electrolyte Panel (Sodium, Potassium, Magnesium, Calcium): To identify electrolyte imbalances.
  • Blood Glucose: To rule out hypoglycemia or hyperglycemia.
  • Complete Blood Count (CBC): To assess for anemia or infection (elevated white blood cell count).
  • Thyroid Function Tests (TSH, Free T4): To evaluate for hyperthyroidism.
  • Toxicology Screen: If substance use or medication overdose is suspected.

Figure: 12-lead ECG demonstrating sinus tachycardia. Example of a normal sinus rhythm with an elevated heart rate, a key characteristic for the differential diagnosis of tachycardia.

Differential Diagnosing Tachycardia: Distinguishing Key Arrhythmias

The differential diagnosis of tachycardia involves distinguishing sinus tachycardia from other tachydysrhythmias and identifying the underlying cause.

Key Differentiations:

  • Sinus Tachycardia vs. Normal Sinus Rhythm: Both have identical ECG features (P waves preceding each QRS complex, normal PR and QRS intervals), differing only in heart rate. Sinus tachycardia exceeds 100 bpm, while normal sinus rhythm is between 60-100 bpm.

  • Sinus Tachycardia vs. Supraventricular Tachycardias (SVTs): SVTs also have narrow QRS complexes but often present with abrupt onset and termination (paroxysmal), very rapid rates (often >150 bpm), and may have absent or abnormal P waves. Specific SVT types (AVNRT, AVRT, atrial flutter, atrial fibrillation) are differentiated by ECG characteristics and clinical context.

  • Sinus Tachycardia vs. Ventricular Tachycardia (VT): VT is distinguished by a wide QRS complex (>120 ms) on ECG. VT is generally more serious and requires prompt evaluation for underlying structural heart disease or ischemia.

  • Inappropriate Sinus Tachycardia (IST) vs. Physiological Sinus Tachycardia: IST is diagnosed after excluding all identifiable physiological and pathological causes for persistent sinus tachycardia at rest. It is often characterized by an exaggerated heart rate response to minimal exertion.

  • Postural Orthostatic Tachycardia Syndrome (POTS) vs. Orthostatic Hypotension: POTS is defined by an excessive heart rate increase upon standing (≥30 bpm or >120 bpm within 10 minutes) without a significant drop in blood pressure (orthostatic hypotension).

Management Strategies Based on Differential Diagnosis

Treatment of tachycardia is directed at the underlying cause.

  • Physiological Sinus Tachycardia: Often resolves spontaneously with rest and addressing the trigger (e.g., pain management, anxiety reduction). No specific cardiac treatment is usually needed.

  • Pathological Tachycardia: Management focuses on treating the underlying medical condition.

    • Sepsis, Shock, Hypoxia, ACS, PE: Require urgent medical intervention, including hospitalization, hemodynamic support, oxygen therapy, and specific treatments for the underlying condition (antibiotics for sepsis, revascularization for ACS, anticoagulation for PE).
    • Electrolyte Imbalances, Hypoglycemia, Dehydration: Correcting the underlying metabolic derangement is crucial.
    • Hyperthyroidism, Pheochromocytoma: Require specific medical or surgical management of the endocrine disorder.
    • Medication-induced Tachycardia: Discontinuation of the offending medication if possible.

  • Inappropriate Sinus Tachycardia (IST) and POTS: Management is often challenging and may involve lifestyle modifications (increased fluid and salt intake, exercise), medications (beta-blockers, ivabradine), and cardiac rehabilitation in some cases.

Prognosis and Potential Complications

The prognosis of tachycardia depends heavily on the underlying etiology. Physiological sinus tachycardia is benign and self-limiting. However, persistent tachycardia due to pathological causes can lead to:

  • Myocardial Ischemia: Increased myocardial oxygen demand due to rapid heart rate.
  • Reduced Ventricular Filling Time: Impaired cardiac output.
  • Heart Failure: Chronic tachycardia can contribute to cardiomyopathy.
  • End-Organ Damage: Due to reduced tissue perfusion in severe cases.
  • Cardiac Arrest and Sudden Death: Especially with ventricular tachyarrhythmias.

Early diagnosis and management of the underlying cause are critical for improving patient outcomes.

Deterrence and Patient Education

Patient education is vital. Individuals should understand that while tachycardia is often normal, persistent or symptomatic tachycardia warrants medical evaluation. Patients should be advised to seek prompt medical attention if they experience tachycardia accompanied by chest pain, shortness of breath, dizziness, or syncope. Education on modifiable risk factors, such as managing stress, avoiding excessive caffeine and stimulants, and maintaining hydration, can also be beneficial.

Enhancing Healthcare Team Outcomes

Effective management of tachycardia, especially in hospitalized patients, requires a collaborative interprofessional team approach. Early warning systems incorporating heart rate monitoring are crucial for detecting clinical deterioration. Nurses play a vital role in accurate vital sign monitoring and recognizing trends. Physicians, nurse practitioners, and physician assistants utilize these data along with clinical assessments to identify underlying causes and initiate timely interventions. Rapid response teams, pharmacists, critical care specialists, and cardiologists may be involved depending on the complexity and underlying etiology of the tachycardia. Effective communication and collaboration among team members are essential to ensure patient safety and optimize outcomes.

Review Questions (for self-assessment and continuing education)

(Note: Review questions from the original article are available via the provided link for continuing education purposes.)

References

(References are identical to the original article and are included for completeness.)

  1. Yusuf S, Camm AJ. The sinus tachycardias. Nat Clin Pract Cardiovasc Med. 2005 Jan;2(1):44-52. PubMed: 16265342
  2. Yusuf S, Camm AJ. Deciphering the sinus tachycardias. Clin Cardiol. 2005 Jun;28(6):267-76. PMC free article: PMC6654702 PubMed: 16028460
  3. KOSSMANN CE. The normal electrocardiogram. Circulation. 1953 Dec;8(6):920-36. PubMed: 13106913
  4. Fleming S, Thompson M, Stevens R, Heneghan C, Plüddemann A, Maconochie I, Tarassenko L, Mant D. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011 Mar 19;377(9770):1011-8. PMC free article: PMC3789232 PubMed: 21411136
  5. Bibas L, Levi M, Essebag V. Diagnosis and management of supraventricular tachycardias. CMAJ. 2016 Dec 06;188(17-18):E466-E473. PMC free article: PMC5135523 PubMed: 27777258
  6. Foth C, Gangwani MK, Ahmed I, Alvey H. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 30, 2023. Ventricular Tachycardia. PubMed: 30422549
  7. Nachimuthu S, Assar MD, Schussler JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf. 2012 Oct;3(5):241-53. PMC free article: PMC4110870 PubMed: 25083239
  8. Sauer AJ, Newton-Cheh C. Clinical and genetic determinants of torsade de pointes risk. Circulation. 2012 Apr 03;125(13):1684-94. PMC free article: PMC3347483 PubMed: 22474311
  9. Blauwet LA, Cooper LT. Myocarditis. Prog Cardiovasc Dis. 2010 Jan-Feb;52(4):274-88. PMC free article: PMC5951175 PubMed: 20109598
  10. Stashko E, Meer JM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 7, 2023. Cardiac Tamponade. PubMed: 28613742
  11. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc. 2009 Oct;84(10):917-38. PMC free article: PMC2755812 PubMed: 19797781
  12. Lavorini F, Di Bello V, De Rimini ML, Lucignani G, Marconi L, Palareti G, Pesavento R, Prisco D, Santini M, Sverzellati N, Palla A, Pistolesi M. Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. Multidiscip Respir Med. 2013 Dec 19;8(1):75. PMC free article: PMC3878229 PubMed: 24354912
  13. Nishiyama KH, Saboo SS, Tanabe Y, Jasinowodolinski D, Landay MJ, Kay FU. Chronic pulmonary embolism: diagnosis. Cardiovasc Diagn Ther. 2018 Jun;8(3):253-271. PMC free article: PMC6039808 PubMed: 30057874
  14. Adeyinka A, Pierre L. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Oct 31, 2022. Fat Embolism. PubMed: 29763060
  15. Kaur K, Bhardwaj M, Kumar P, Singhal S, Singh T, Hooda S. Amniotic fluid embolism. J Anaesthesiol Clin Pharmacol. 2016 Apr-Jun;32(2):153-9. PMC free article: PMC4874066 PubMed: 27275041
  16. Gordy S, Rowell S. Vascular air embolism. Int J Crit Illn Inj Sci. 2013 Jan;3(1):73-6. PMC free article: PMC3665124 PubMed: 23724390
  17. Cafaro RP. Hypoxia: Its Causes and Symptoms. J Am Dent Soc Anesthesiol. 1960 Apr;7(4):4-8. PMC free article: PMC2067517 PubMed: 19598857
  18. Mathew P, Thoppil D. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Dec 26, 2022. Hypoglycemia. PubMed: 30521262
  19. Popkin BM, D’Anci KE, Rosenberg IH. Water, hydration, and health. Nutr Rev. 2010 Aug;68(8):439-58. PMC free article: PMC2908954 PubMed: 20646222
  20. Simon LV, Hashmi MF, Farrell MW. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Sep 4, 2023. Hyperkalemia. PubMed: 29261936
  21. Pham PC, Pham PA, Pham SV, Pham PT, Pham PM, Pham PT. Hypomagnesemia: a clinical perspective. Int J Nephrol Renovasc Dis. 2014;7:219-30. PMC free article: PMC4062555 PubMed: 24966690
  22. Schafer AL, Shoback DM. Hypocalcemia: Diagnosis and Treatment. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP, editors. Endotext [Internet]. MDText.com, Inc.; South Dartmouth (MA): Jan 3, 2016. PubMed: 25905251
  23. Lever A, Mackenzie I. Sepsis: definition, epidemiology, and diagnosis. BMJ. 2007 Oct 27;335(7625):879-83. PMC free article: PMC2043413 PubMed: 17962288
  24. Haseer Koya H, Paul M. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Jul 24, 2023. Shock. PubMed: 30285387
  25. Johnson AB, Burns B. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8, 2023. Hemorrhage. PubMed: 31194413
  26. Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Crit Care. 2004 Oct;8(5):373-81. PMC free article: PMC1065003 PubMed: 15469601
  27. Klein HH, Pich S. [Cardiovascular changes during pregnancy]. Herz. 2003 May;28(3):173-4. PubMed: 12756474
  28. Reid JR, Wheeler SF. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2005 Aug 15;72(4):623-30. PubMed: 16127951
  29. Asa SL, Ezzat S, Mete O. The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations. J Clin Med. 2018 Sep 13;7(9) PMC free article: PMC6162705 PubMed: 30217041
  30. Olshansky B, Sullivan RM. Inappropriate sinus tachycardia. Europace. 2019 Feb 01;21(2):194-207. PubMed: 29931244
  31. Pellegrini CN, Scheinman MM. Epidemiology and definition of inappropriate sinus tachycardia. J Interv Card Electrophysiol. 2016 Jun;46(1):29-32. PubMed: 26310298
  32. Still AM, Raatikainen P, Ylitalo A, Kauma H, Ikäheimo M, Antero Kesäniemi Y, Huikuri HV. Prevalence, characteristics and natural course of inappropriate sinus tachycardia. Europace. 2005 Mar;7(2):104-12. PubMed: 15763524
  33. Zadourian A, Doherty TA, Swiatkiewicz I, Taub PR. Postural Orthostatic Tachycardia Syndrome: Prevalence, Pathophysiology, and Management. Drugs. 2018 Jul;78(10):983-994. PubMed: 29943373
  34. Agarwal AK, Garg R, Ritch A, Sarkar P. Postural orthostatic tachycardia syndrome. Postgrad Med J. 2007 Jul;83(981):478-80. PMC free article: PMC2600095 PubMed: 17621618
  35. Chin A, Vezi B, Namane M, Weich H, Scott-Millar R. An approach to the patient with a suspected tachycardia in the emergency department. S Afr Med J. 2016 Mar;106(3):246-50. PubMed: 27303760
  36. Ruzieh M, Moustafa A, Sabbagh E, Karim MM, Karim S. Challenges in Treatment of Inappropriate Sinus Tachycardia. Curr Cardiol Rev. 2018 Mar 14;14(1):42-44. PMC free article: PMC5872261 PubMed: 29189171
  37. Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013 Oct 31;369(18):1726-34. PubMed: 24171518
  38. Van Dam MN, Hashmi MF, Fitzgerald BM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 28, 2024. Pulsus Paradoxus. PubMed: 29493917
  39. Craige E. Gallop rhythm. Prog Cardiovasc Dis. 1967 Nov;10(3):246-61. PubMed: 4865414
  40. Grace RF. Pulse oximetry. Gold standard or false sense of security? Med J Aust. 1994 May 16;160(10):638-44. PubMed: 8177111
  41. Thomas JT, Kelly RF, Thomas SJ, Stamos TD, Albasha K, Parrillo JE, Calvin JE. Utility of history, physical examination, electrocardiogram, and chest radiograph for differentiating normal from decreased systolic function in patients with heart failure. Am J Med. 2002 Apr 15;112(6):437-45. PubMed: 11959053
  42. Lee SM, An WS. New clinical criteria for septic shock: serum lactate level as new emerging vital sign. J Thorac Dis. 2016 Jul;8(7):1388-90. PMC free article: PMC4958885 PubMed: 27501243
  43. Sajadi-Ernazarova KR, Martin J, Gupta N. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 8, 2023. Acute Pneumothorax Evaluation and Treatment. PubMed: 30855900
  44. Corrigan D, Prucnal C, Kabrhel C. Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients. Clin Exp Emerg Med. 2016 Sep;3(3):117-125. PMC free article: PMC5065342 PubMed: 27752629
  45. Reno CM, Daphna-Iken D, Chen YS, VanderWeele J, Jethi K, Fisher SJ. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes. 2013 Oct;62(10):3570-81. PMC free article: PMC3781452 PubMed: 23835337
  46. Hoffman RS. Treatment of patients with cocaine-induced arrhythmias: bringing the bench to the bedside. Br J Clin Pharmacol. 2010 May;69(5):448-57. PMC free article: PMC2856045 PubMed: 20573080
  47. Peyrol M, Lévy S. Clinical presentation of inappropriate sinus tachycardia and differential diagnosis. J Interv Card Electrophysiol. 2016 Jun;46(1):33-41. PubMed: 26329720
  48. Patti L, Ashurst JV. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 7, 2023. Supraventricular Tachycardia. PubMed: 28723001
  49. Imrie JR, Yee R, Klein GJ, Sharma AD. Incidence and clinical significance of ST segment depression in supraventricular tachycardia. Can J Cardiol. 1990 Oct;6(8):323-6. PubMed: 2268794
  50. Dang D, Arimie R, Haywood LJ. A review of atrial fibrillation. J Natl Med Assoc. 2002 Dec;94(12):1036-48. PMC free article: PMC2568400 PubMed: 12510703
  51. Cosío FG. Atrial Flutter, Typical and Atypical: A Review. Arrhythm Electrophysiol Rev. 2017 Jun;6(2):55-62. PMC free article: PMC5522718 PubMed: 28835836
  52. Cossú SF, Steinberg JS. Supraventricular tachyarrhythmias involving the sinus node: clinical and electrophysiologic characteristics. Prog Cardiovasc Dis. 1998 Jul-Aug;41(1):51-63. PubMed: 9717859
  53. Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome (POTS). J Cardiovasc Electrophysiol. 2009 Mar;20(3):352-8. PMC free article: PMC3904426 PubMed: 19207771
  54. Armen SB, Freer CV, Showalter JW, Crook T, Whitener CJ, West C, Terndrup TE, Grifasi M, DeFlitch CJ, Hollenbeak CS. Improving Outcomes in Patients With Sepsis. Am J Med Qual. 2016 Jan-Feb;31(1):56-63. PMC free article: PMC5731488 PubMed: 25216849
  55. Leeper B, Cyr AM, Lambert C, Martin K. Acute coronary syndrome. Crit Care Nurs Clin North Am. 2011 Dec;23(4):547-57. PubMed: 22118113
  56. Gopinathannair R, Olshansky B. Management of tachycardia. F1000Prime Rep. 2015;7:60. PMC free article: PMC4447058 PubMed: 26097733
  57. Ludikhuize J, Smorenburg SM, de Rooij SE, de Jonge E. Identification of deteriorating patients on general wards; measurement of vital parameters and potential effectiveness of the Modified Early Warning Score. J Crit Care. 2012 Aug;27(4):424.e7-13. PubMed: 22341727
  58. van Galen LS, Dijkstra CC, Ludikhuize J, Kramer MH, Nanayakkara PW. A Protocolised Once a Day Modified Early Warning Score (MEWS) Measurement Is an Appropriate Screening Tool for Major Adverse Events in a General Hospital Population. PLoS One. 2016;11(8):e0160811. PMC free article: PMC4975404 PubMed: 27494719
  59. Kause J, Smith G, Prytherch D, Parr M, Flabouris A, Hillman K., Intensive Care Society (UK). Australian and New Zealand Intensive Care Society Clinical Trials Group. A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admissions in Australia and New Zealand, and the United Kingdom–the ACADEMIA study. Resuscitation. 2004 Sep;62(3):275-82. PubMed: 15325446
  60. Ludikhuize J, Borgert M, Binnekade J, Subbe C, Dongelmans D, Goossens A. Standardized measurement of the Modified Early Warning Score results in enhanced implementation of a Rapid Response System: a quasi-experimental study. Resuscitation. 2014 May;85(5):676-82. PubMed: 24561029
  61. Cavanaugh JB, Sullivan JB, East N, Nodzon JN. Importance of Pharmacy Involvement in the Treatment of Sepsis. Hosp Pharm. 2017 Mar;52(3):191-197. PMC free article: PMC5396986 PubMed: 28439133
  62. Cohen RI, Eichorn A, Motschwiller C, Laktikova V, La Torre G, Ginsberg N, Steinberg H. Medical intensive care unit consults occurring within 48 hours of admission: a prospective study. J Crit Care. 2015 Apr;30(2):363-8. PubMed: 25465025
  63. Schellings DA, Symersky T, Ottervanger JP, Ramdat Misier AR, de Boer MJ. Clinical cardiology consultation at non-cardiology departments: stepchild of patient care? Neth Heart J. 2012 Jun;20(6):260-3. PMC free article: PMC3370090 PubMed: 22644999
  64. Mayuga KA, Fedorowski A, Ricci F, Gopinathannair R, Dukes JW, Gibbons C, Hanna P, Sorajja D, Chung M, Benditt D, Sheldon R, Ayache MB, AbouAssi H, Shivkumar K, Grubb BP, Hamdan MH, Stavrakis S, Singh T, Goldberger JJ, Muldowney JAS, Belham M, Kem DC, Akin C, Bruce BK, Zahka NE, Fu Q, Van Iterson EH, Raj SR, Fouad-Tarazi F, Goldstein DS, Stewart J, Olshansky B. Sinus Tachycardia: a Multidisciplinary Expert Focused Review. Circ Arrhythm Electrophysiol. 2022 Sep;15(9):e007960. PMC free article: PMC9523592 PubMed: 36074973

Disclosure: Allison Henning declares no relevant financial relationships with ineligible companies.

Disclosure: Conrad Krawiec declares no relevant financial relationships with ineligible companies.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *